The Committees vote is advisory, FDA will make the ultimate determination, and many of the most important questions remain unresolvedincluding how real-world evidence should be weighed, what quality standards should apply, and whether a guarded pathway can move existing use into a more regulated framework
While Retatrutide is in Phase 3 clinical trials and not yet FDA-approved in the US, Canadian researchers can access it through domestic research peptide suppliers
Reconstituted product should be refrigerated at 28C and used within the window noted on the COA
The recommended dose varies by form: oral glutathione (250 mg to 1,000 mg), liposomal glutathione (100 mg to 500 mg), and intravenous glutathione (600 mg to 1,200 mg)
Wound healing studies in human subjects document accelerated re-epithelialization, reduced inflammatory markers (IL-1, TNF-), and improved tissue tensile strength in GHK-Cu treated wounds compared to controls